Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ·Healthcare·Biotechnology
$4.51
—
Mkt Cap $3.37M
No analyst coverage available
We don't have analyst ratings or price target data for Galmed Pharmaceuticals Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.